Sort by
Keyphrases
Breast Cancer
78%
Triple-negative Breast Cancer
66%
Histone Chaperone
58%
MicroRNA
57%
Signaling Pathway
53%
COVID-19
44%
Subtype-specific
44%
Breast Cancer Subtypes
41%
ANP32E
41%
Replication-independent
41%
CENP-A
41%
Mammalian Target of Rapamycin (mTOR)
40%
Histone Variants
37%
Tumor
34%
Qatar
33%
NK Cell Subsets
33%
Circular RNA Profile
33%
Centromere Protein A
33%
Amino-terminus
33%
Microscopy Data
33%
3D Voronoi Tessellation
33%
3D Clustering
33%
Thymoquinone
33%
Auto-ubiquitination
33%
UHRF1
33%
Genetic Code Reprogramming
33%
CD4+ T
33%
Neuromotor Development
33%
Apoptosis Induction
33%
Sub-network Enrichment Analysis
33%
MicroRNA Regulatory Network
33%
HJURP
33%
Transcriptomic Network
33%
Rosette-like
33%
Therapeutic Molecular Targets
33%
Multi-ethnic
33%
Humoral Response
33%
Braking
33%
Mucin
33%
T Cell Immunoglobulin mucin-3
33%
Immunoglobulin
33%
Tumor-infiltrating
33%
Regulatory Complexity
33%
Regulatory T (Treg) Cells
33%
Death-associated Protein
33%
FoxP3+
33%
Tripartite Motif
33%
PIWI-interacting RNA (piRNA)
33%
TIF1
33%
Tumor Suppression
33%
Biochemistry, Genetics and Molecular Biology
Histone
100%
Poly ADP Ribose Polymerase
66%
T Cell
66%
CD4
50%
DNA Binding
44%
Super-Resolution Microscopy
41%
Blood Plasma
41%
MicroRNA
40%
Cryo-Electron Microscopy
38%
Transcription
37%
Regulatory Network
33%
Gene Expression Profiling
33%
Centromere
33%
UHRF1
33%
Rosette Formation
33%
N-Terminus
33%
Tretinoin
33%
Retinoic Acid
33%
Intravenous Immunoglobulin
33%
Mucin
33%
Piwi-Interacting RNA
33%
Endogenous Retrovirus
33%
Proteome
33%
Amyloid Precursor Protein
33%
Amyloid
33%
Solution and Solubility
33%
Transcription Initiation Site
33%
Small Molecule
33%
Nucleic Acid
33%
Zinc Finger Motif
33%
Animal Disease Model
33%
Tau
33%
Pharmacophore
33%
Tau Protein
33%
Long Non-Coding RNA
33%
Long Noncoding RNA
33%
Ubiquitination
33%
DDX21
33%
Histone Variant
33%
Prevalence
33%
Genetic Risk
33%
Circular RNA
33%
Omics Approaches
33%
Natural Killer Cell
33%
Tumor Necrosis Factor
33%
Somatic Mutation
33%
Exome Sequencing
33%
Messenger RNA
28%
Histone H3
27%
Nucleotide Excision Repair
27%
